161 related articles for article (PubMed ID: 34051318)
1. Injectable thermoresponsive gels offer sustained dual release of bupivacaine hydrochloride and ketorolac tromethamine for up to two weeks.
Abdeltawab H; Svirskis D; Boyd BJ; Hill A; Sharma M
Int J Pharm; 2021 Jul; 604():120748. PubMed ID: 34051318
[TBL] [Abstract][Full Text] [Related]
2. In situ gelling system for sustained intraarticular delivery of bupivacaine and ketorolac in sheep.
Abdeltawab H; Bolam SM; Jaiswal JK; McGlashan SR; Young SW; Hill A; Svirskis D; Sharma M
Eur J Pharm Biopharm; 2022 May; 174():35-46. PubMed ID: 35364255
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
4. Increasing the Hydrophobic Component of Poloxamers and the Inclusion of Salt Extend the Release of Bupivacaine from Injectable In Situ Gels, While Common Polymer Additives Have Little Effect.
Abdeltawab H; Svirskis D; Hill AG; Sharma M
Gels; 2022 Aug; 8(8):. PubMed ID: 36005085
[TBL] [Abstract][Full Text] [Related]
5. Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use.
Abdeltawab H; Jaiswal JK; Young SW; Svirskis D; Hill A; Sharma M
Eur J Hosp Pharm; 2023 Mar; 30(e1):e48-e54. PubMed ID: 34663584
[TBL] [Abstract][Full Text] [Related]
6. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
7. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan.
Li C; Li C; Liu Z; Li Q; Yan X; Liu Y; Lu W
Int J Pharm; 2014 Oct; 474(1-2):123-33. PubMed ID: 25138250
[TBL] [Abstract][Full Text] [Related]
8. Injectable thermosensitive gelling delivery system for the sustained release of lidocaine.
Svirskis D; Chandramouli K; Bhusal P; Wu Z; Alphonso J; Chow J; Patel D; Ramakrishna R; Yeo SJ; Stowers R; Hill A; Munro J; Young SW; Sharma M
Ther Deliv; 2016 Jun; 7(6):359-68. PubMed ID: 27250538
[TBL] [Abstract][Full Text] [Related]
9. Sustained release of ketorolac tromethamine from poloxamer 407/cellulose nanofibrils graft nanocollagen based ophthalmic formulations.
Orasugh JT; Dutta S; Das D; Pal C; Zaman A; Das S; Dutta K; Banerjee R; Ghosh SK; Chattopadhyay D
Int J Biol Macromol; 2019 Nov; 140():441-453. PubMed ID: 31437512
[TBL] [Abstract][Full Text] [Related]
10. Injectable In Situ Gelling System for Sustained Nicotine Delivery as a Replacement Therapy for Smoking Cessation.
Hulambukie E; Abdeltawab H; Duarah S; Svirskis D; Sharma M
Gels; 2022 Feb; 8(2):. PubMed ID: 35200495
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy.
Gandra SC; Nguyen S; Nazzal S; Alayoubi A; Jung R; Nesamony J
Pharm Dev Technol; 2015 Jan; 20(1):41-9. PubMed ID: 24160864
[TBL] [Abstract][Full Text] [Related]
12. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
Abdeltawab H; Svirskis D; Sharma M
Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
[No Abstract] [Full Text] [Related]
13. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery.
Morsi N; Ghorab D; Refai H; Teba H
Int J Pharm; 2016 Jun; 506(1-2):57-67. PubMed ID: 27091293
[TBL] [Abstract][Full Text] [Related]
14. Physiologically activated phase transition systems for improved ocular retention of ketorolac tromethamine.
Thakor S; Vhora I; Desai J; Thakkar S; Thakkar H
J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S6-7. PubMed ID: 23066208
[TBL] [Abstract][Full Text] [Related]
15. A Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin.
Wang B; Shao J; Jansen JA; Walboomers XF; Yang F
J Dent Res; 2019 Mar; 98(3):355-362. PubMed ID: 30403904
[TBL] [Abstract][Full Text] [Related]
16. Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications.
Soliman KA; Ullah K; Shah A; Jones DS; Singh TRR
Drug Discov Today; 2019 Aug; 24(8):1575-1586. PubMed ID: 31175956
[TBL] [Abstract][Full Text] [Related]
17. Sustained Delivery of Lactoferrin Using Poloxamer Gels for Local Bone Regeneration in a Rat Calvarial Defect Model.
Park YE; Chandramouli K; Watson M; Zhu M; Callon KE; Tuari D; Abdeltawab H; Svirskis D; Musson DS; Sharma M; Cornish J
Materials (Basel); 2021 Dec; 15(1):. PubMed ID: 35009359
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
[TBL] [Abstract][Full Text] [Related]
19. Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.
Mallandrich M; Fernández-Campos F; Clares B; Halbaut L; Alonso C; Coderch L; Garduño-Ramírez ML; Andrade B; Del Pozo A; Lane ME; Calpena AC
Pharm Res; 2017 Aug; 34(8):1728-1740. PubMed ID: 28540502
[TBL] [Abstract][Full Text] [Related]
20. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
